Volume 3, Number 2—June 1997
Synopsis
Borna Disease
Carolyn G. Hatalski, Ann J. Lewis, and W. Ian Lipkin
Table 1
Serum immunoreactivity to Borna disease virus in various diseases
| Prevalence |
||||||
|---|---|---|---|---|---|---|
| Disease | Disease | (%) | Controls | (%) | Assay | Ref. |
| Psychiatric | (4/694) | 0.6 | (0/200) | 0 | IFA | (36) |
| (various) | (13/642) | 2 | (11/540) | 2 | IFA | (60) |
| (200-350/5000) | 4-7 | (10/1000) | 1 | WB IFA / | (61) | |
| (18/60) | 30 | (1/100) | 1 | WB | (24, 25) | |
| (18/132) | 13.6 | (3/203) | 1.5 | WB | (27) | |
| (13/55) | 23.6 | (4/36) | 11.1 | IFA | (51) | |
| (6/49) | 12.2 | IFA | (38) | |||
| Affective | (12/265) | 4.5 | (0/105) | 0 | IFA | (62) |
| (12/285) | 4.2 | (0/200) | 0 | IFA | (36) | |
| (53/138) | 38 | (19/117) | 16 | WB | (37) | |
| (6/52) | 11.5 | (3/203) | 1.4 | WB | (27) | |
| (10/27) | 37 | IFA | (38) | |||
| Schizophrenia | (29/90) | 32 | (4/20) | 20 | WB | (43) |
| (16/114) | 14 | (3/203) | 1.5 | WB | (27) | |
| (1/4) | 25 | IFA | (38) | |||
| CFS | (6/25) | 24 | WB | (26) | ||
| MS | (15/114) | 13 | (10/483) | 2.1 | IP/ IFA | (63) |
| HIV-positive | (36/460) | 7.8 | (11/540) | 2 | IFA | (60) |
| HIV-early | (61/751) | 8.1 | (10/483) | 2 | IP/ IFA | (61) |
| HIV-LAP | (34/244) | 14 | (10/483) | 2 | IP/ IFA | (63) |
| Schisto/malaria | (19/193) | 9.8 | (10/483) | 2 | IP/IFA | (63) |
Abbreviations: IFA, immunofluorescence assay; WB, Western immunoblot; IP, immunoprecipitation; CFS, chronic fatigue syndrome; MS, multiple sclerosis; HIV, human immunodeficiency virus; LAP, lymphadenopathy; Schisto/malaria, schistosomiasis or malaria.
